Artificial neural networks were used to decipher gene-expression signatures collected with DNA microarrays and to classify cancers into specific categories. Will this technology lead to better diagnostic tools and new therapeutic targets? (pages 673–679)
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pizzo, P.A. Principles and practice of pediatric oncology (Lippincott-Raven, Philadelphia, 1997).
Golub, T.R. et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286, 531–537 (1999).
Alizadeh, A.A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511 (2000).
Bittner, M. et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536–540 (2000).
Hedenfalk, I. et al. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med . 344, 539–548 (2001).
Khan, J. et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial networks. Nature Med. 7, 673–679 (2001).
Marton, M.J. et al. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nature Med. 4, 1293–1301 (1998).
Roberts, C.J. et al. Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles. Science 287, 873–880 (2000).
Hughes, T.R. et al. Functional discovery via a compendium of expression profiles. Cell 102, 109–126 (2000).
Shoemaker, D.D. et al. Experimental annotation of the human genome using microarray technology. Nature 409, 922–927 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
He, Y., Friend, S. Microarrays—the 21st century divining rod?. Nat Med 7, 658–659 (2001). https://doi.org/10.1038/89022
Issue Date:
DOI: https://doi.org/10.1038/89022
This article is cited by
-
Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry
Breast Cancer Research (2010)
-
Genomweite Expressionsprofile als klinische Entscheidungshilfe
Der Pathologe (2009)
-
Prognostic factors affecting the natural history of node-negative breast cancer
Breast Cancer Research and Treatment (2005)
-
Differential expression of DOC-1 in microsatellite-unstable human colorectal cancer
Oncogene (2003)
-
Gene expression profiling predicts clinical outcome of breast cancer
Nature (2002)